About DIA Europe 2026
DIA’s European regional annual meeting - the largest neutral conference in the European life sciences arena for the last 38 years!
For the first time, DIA Europe will take place in the vibrant city of Rotterdam from 24-26 March 2026, welcoming 1500 professionals from over 50 countries.
As the largest neutral conference in the European life sciences arena, this event continues to be a cornerstone for advancing innovation, collaboration, and impactful decision-making.
This year’s programme features 10 dynamic tracks, including new focus areas that reflect the evolving landscape of life sciences. Explore cutting-edge topics across Clinical Trials Innovation, Artificial Intelligence & RWE, Innovative Therapies, Medical Devices, Pharmacovigilance, and more.
With over 80 sessions, contributions from 300+ expert speakers and panelists, and the active participation of 40+ regulatory authorities, 15+ HTA bodies and payers, and 20+ patient organizations, DIA Europe 2026 promises unparalleled value and insights.
What No Other Congress Offers
- Exclusive Knowledge Gain cutting-edge insights from over 300 global experts, including leaders from 40+ regulatory authorities and 15+ HTA bodies, sharing the latest developments in healthcare, policy, and innovation.
- Unmatched Diversity Experience a unique multi-stakeholder forum with perspectives from patients, regulators, researchers, payers, and industry professionals, fostering meaningful collaboration and dialogue.
- Future-Focused Topics Dive deep into emerging areas such as Artificial Intelligence, Precision Medicine, Regulatory Strategy, and Market Access with 10 tracks and 80+ sessions designed to prepare you for tomorrow's challenges.
- Trusted Neutral Platform Leverage DIA’s neutral platform to connect with key players, exchange ideas in a collaborative environment, and receive actionable feedback to inform your strategic decisions.
- Unparalleled Networking Opportunities Join 1500+ attendees from over 50 countries to expand your professional network, build lasting connections, and collaborate on driving innovation in life sciences.